Fig. 6.
Fig. 6. Circulating human cells in the peripheral blood of NOD/SCID mice. / Peripheral blood cells from the same mouse were gated as described above (A) and tested for expression of human CD45, a human-specific panleukocyte marker (B). Human primitive CD133+CD34−CD38− (C) and CD133+CD34+CD38+ (D) stem cells were detected. CD19 (a human pan–B-cell marker; E), CD56 (an NK-cell marker; F), and CD3 (a human pan–T-cell marker; E-F) were also expressed. Human cells with a T-cell phenotype expressed CD2 (G) as well as CD4 and CD8 (H), and the majority of them expressed TCRγδ (I).

Circulating human cells in the peripheral blood of NOD/SCID mice.

Peripheral blood cells from the same mouse were gated as described above (A) and tested for expression of human CD45, a human-specific panleukocyte marker (B). Human primitive CD133+CD34CD38 (C) and CD133+CD34+CD38+ (D) stem cells were detected. CD19 (a human pan–B-cell marker; E), CD56 (an NK-cell marker; F), and CD3 (a human pan–T-cell marker; E-F) were also expressed. Human cells with a T-cell phenotype expressed CD2 (G) as well as CD4 and CD8 (H), and the majority of them expressed TCRγδ (I).

Close Modal

or Create an Account

Close Modal
Close Modal